title: The Legal Implications of Detecting Alzheimer's Disease Earlier.
abstract: Early detection of Alzheimer's disease (AD) raises a number of challenging legal questions. In this essay, we explore some of those questions, such as: Is a neurological indicator of increased risk for AD a legally relevant brain state before there are any outward behavioral manifestations? How should courts address evidentiary challenges to the admissibility of AD-related neuroimaging? How should the government regulate the marketing of neuroimaging diagnostic tools? How should insurance coverage for the use of these new tools be optimized? We suggest that many voices and multidisciplinary perspectives are needed to answer these questions and ensure that legal responses are swift, efficient, and equitable.
authors.affiliation: Research assistant in the Shen Neurolaw Lab at the University of Minnesota Law School in the Twin Cities, and a research fellow at the Center for Science and Law at Baylor College of Medicine. His work focuses on the intersection of law, neuroscience, and public policy.
authors.forename: Joshua
authors.initials: J
authors.lastname: Preston
authors.forename: Jaleh
authors.initials: J
authors.lastname: McTeigue
authors.affiliation: Research assistant in the Shen Neurolaw Lab at the University of Minnesota Law School in the Twin Cities.
authors.forename: Caitlin
authors.initials: C
authors.lastname: Opperman
authors.affiliation: Research assistant in the Shen Neurolaw Lab at the University of Minnesota in the Twin Cities.
authors.forename: Jordan Dean
authors.initials: JD
authors.lastname: Scott Krieg
authors.affiliation: Research assistant in the Shen Neurolaw Lab at the University of Minnesota in the Twin Cities.
authors.forename: Mikaela
authors.initials: M
authors.lastname: Brandt-Fontaine
authors.affiliation: Research assistant in the Shen Neurolaw Lab at the University of Minnesota in the Twin Cities.
authors.forename: Alina
authors.initials: A
authors.lastname: Yasis
authors.affiliation: Associate professor of law at the University of Minnesota in the Twin Cities, where he also serves as director of the Shen Neurolaw Lab, and executive director of education and outreach for the MacArthur Foundation Research Network on Law and Neuroscience and a faculty member at the Center for Law, Brain and Behavior at Massachusetts General Hospital.
authors.forename: Francis X
authors.initials: FX
authors.lastname: Shen
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis* / Q000000981:diagnostic imaging; D001519:Behavior; D015415:Biomarkers; D001921:Brain / Q000000981:diagnostic imaging*; D042241:Early Diagnosis; D006801:Humans; D019458:Insurance Coverage; D033222:Judicial Role; D040541:Marketing; D059906:Neuroimaging / Q000379:methods*; D018570:Risk Assessment
chemical_list: D015415:Biomarkers